Notice of Exempt Offering of Securities, item 06b



>




X0708


D


LIVE



0001755237


Cyclerion Therapeutics, Inc.



245 First Street, 18th Floor


CAMBRIDGE


MA


MASSACHUSETTS


02142



(857) 327-8778


MASSACHUSETTS



None




None



Corporation



true


2018







Peter


M.


Hecht




245 First Street, 18th Floor


Cambridge


MA


MASSACHUSETTS


02142




Executive Officer


Director






Andreas


Busch




245 First Street, 18th Floor


Cambridge


MA


MASSACHUSETTS


02142




Executive Officer






Anjeza


Gjino




245 First Street, 18th Floor


Cambridge


MA


MASSACHUSETTS


02142




Executive Officer






Cheryl


Gault




245 First Street, 18th Floor


Cambridge


MA


MASSACHUSETTS


02142




Executive Officer






Kevin


Churchwell




245 First Street, 18th Floor


Cambridge


MA


MASSACHUSETTS


02142




Director






George


Conrades




245 First Street, 18th Floor


Cambridge


MA


MASSACHUSETTS


02142




Director






Errol


De Souza




245 First Street, 18th Floor


Cambridge


MA


MASSACHUSETTS


02142




Director






Marsha


Fanucci




245 First Street, 18th Floor


Cambridge


MA


MASSACHUSETTS


02142




Director






Ole


Isacson




245 First Street, 18th Floor


Cambridge


MA


MASSACHUSETTS


02142




Director






Stephanie


Lovell




245 First Street, 18th Floor


Cambridge


MA


MASSACHUSETTS


02142




Director






Terrance


McGuire




245 First Street, 18th Floor


Cambridge


MA


MASSACHUSETTS


02142




Director






Michael


Mendelsohn




245 First Street, 18th Floor


Cambridge


MA


MASSACHUSETTS


02142




Director







Pharmaceuticals




$1,000,001 - $5,000,000




06b





false




2021-06-07





false




true




false



0





18028000


18028000


0




false


7





0




0






0





false



Cyclerion Therapeutics, Inc.


/s/ Anjeza Gjino


Anjeza Gjino


Chief Financial Officer


2021-06-17







The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Cyclerion Therapeutics, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Current report, items 7.01 and 9.01 - Sept. 30, 2021

Auto Refresh

Feedback